Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PRESTIGE CONSUMER HEALTHCARE INC.

(PBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

DA Davidson Adjusts Price Target on Prestige Consumer Healthcare to $63 from $61, Keeps Neutral Rating

11/15/2021 | 12:08pm EST


© MT Newswires 2021
All news about PRESTIGE CONSUMER HEALTHCARE INC.
01/10Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Third Quarter Earnings Results
AQ
2021PRESTIGE CONSUMER HEALTHCARE : Morgan Stanley Virtual Global Consumer & Retail Conference
PU
2021INSIDER SELL : Prestige Consumer Healthcare
MT
2021DA Davidson Adjusts Price Target on Prestige Consumer Healthcare to $63 from $61, Keeps..
MT
2021Q2 2022 Prestige Consumer Healthcare Inc. Earnings Conference Call
PU
2021Prestige Consumer Healthcare Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2022 Gui..
MT
2021PRESTIGE BRANDS : Fiscal Q2 Earnings Snapshot
AQ
2021PRESTIGE CONSUMER HEALTHCARE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ
2021Prestige Consumer Healthcare Inc. Reports Earnings Results for the Second Quarter and S..
CI
2021Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results - Form 8-K
PU
More news
Analyst Recommendations on PRESTIGE CONSUMER HEALTHCARE INC.
More recommendations
Financials (USD)
Sales 2022 1 060 M - -
Net income 2022 197 M - -
Net Debt 2022 - - -
P/E ratio 2022 14,9x
Yield 2022 -
Capitalization 2 905 M 2 905 M -
Capi. / Sales 2022 2,74x
Capi. / Sales 2023 2,65x
Nbr of Employees 505
Free-Float 91,6%
Chart PRESTIGE CONSUMER HEALTHCARE INC.
Duration : Period :
Prestige Consumer Healthcare Inc. Technical Analysis Chart | PBH | US74112D1019 | MarketScreener
Technical analysis trends PRESTIGE CONSUMER HEALTHCARE INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 57,97 $
Average target price 68,00 $
Spread / Average Target 17,3%
EPS Revisions
Managers and Directors
Ronald M. Lombardi Chairman, President & Chief Executive Officer
Christine Sacco Chief Financial Officer
Jeff Zerillo Senior Vice President-Operations
John E. Byom Independent Director
Sheila A. Hopkins Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PRESTIGE CONSUMER HEALTHCARE INC.-4.42%2 905
JOHNSON & JOHNSON-3.40%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-11.98%220 356